In conclusion, our present study not only facilitate a better understanding of the roles of ROCK1 and ROCK2 in the AH dynamics of HTM and molecular pharmacology of ROCK-is toward HTM, but also may suggests additional insights into potential future therapeutic strategies for the treatment of glaucoma. This evidence concerns the gene ROCK2 and glaucoma.